Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm Metastasis × zanidatamab × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Stomach Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Hemangiosarcoma 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Advanced Malignancies 1

Interventions

Specimen Handling 32 Biopsy 30 Magnetic Resonance Spectroscopy 21 pembrolizumab 18 Nivolumab 12 trastuzumab deruxtecan 9 Paclitaxel 9 Pemetrexed 8 Cisplatin 8 Carboplatin 8 Taxes 7 Leucovorin 6 Irinotecan 6 Ipilimumab 6 Gemcitabine 6 Fulvestrant 6 Fluorouracil 6 Cetuximab 6 Capecitabine 6 130-nm albumin-bound paclitaxel 6 X-Rays 5 Radiosurgery 5 Oxaliplatin 5 Cyclophosphamide 5 abemaciclib 4 Trastuzumab 4 Drug Therapy 4 Doxorubicin 4 tislelizumab 3 talazoparib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡